Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Fluorescently Labeled Bevacizumab in Human Breast Cancer – Defining the Classification Threshold

Not Accessible

Your library or personal account may give you access

Abstract

In-vivo fluorescently labelled drug (bevacizumab) breast cancer specimen where obtained from patients. We propose a new structured method to determine the optimal classification threshold in targeted fluorescence intra-operative imaging.

© 2017 SPIE

PDF Article
More Like This
Confocal Fluorescence Microscopy for Evaluation of Breast Cancer in Human Breast Tissue

J. Dobbs, H. Ding, A. Benveniste, H. Keurer, S. Krishnamurthy, W. Yang, and R. Richards-Kortum
BTu3A.19 Biomedical Optics (BIOMED) 2012

Non-Invasive Characterization of Metabolic Drug Effects on Breast Cancer Cell Spheroids Using Two-Photon Excited Fluorescence Microscopy

Zhiyi Liu, Eugen Dhimolea, Antonio Varone, Constantine S. Mitsiades, and Irene Georgakoudi
OmM4D.2 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2017

Combined Three-Dimensional Magnetic Resonance Guided Optical Spectroscopy for Functional and Molecular Imaging of Human Breast Cancer

Michael A. Mastanduno, Scott C. Davis, Shudong Jiang, Roberta diFlorio-Alexander, Brian W. Pogue, and Keith D. Paulsen
80890A European Conference on Biomedical Optics (ECBO) 2011

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.